Loading clinical trials...
Loading clinical trials...
Evaluation of a Colorectal Cancer Education Training Program
This clinical trial evaluates the effectiveness of trained community engagement specialists for improving communication on colorectal cancer (CRC) prevention and genetic testing among Hispanic/Latino/a/x (H/L) communities. CRC is the second and third leading cause of cancer deaths among United States (US) H/L men and women respectively. Knowledge of inherited germline mutations (changes in a gene that occurs in a sperm or egg cell) is critical for understanding cause of disease and can impact patient treatment options and outcomes. Educational programs and participant engagement approaches focused on H/L individuals considering Latino cultural values, literacy, numeracy, barriers faced, cultural beliefs and attitudes, as well as language of participants are much needed to address these observed disparities. The Community Genetic Navigation Specialists (CoGENES) Program focuses on increasing knowledge, and preparing the CoGENES trainees to help respond to questions, fears, and concerns regarding genetic testing, counseling, biospecimen (sample of urine, blood, or tissue cells) donation and participation in clinical trials to H/L community members, patients and their families. CoGENES may improve communication on colorectal cancer prevention and genetic testing which can help reduce cancer disparities among H/L communities.
PRIMARY OBJECTIVE: I. To develop a local workforce of trained community engagement specialists to act as liaison agents to improve communication on genetic research, clinical genetic testing, and counseling to Hispanic/Latino/a/x (H/L) individuals. OUTLINE: Participants are randomized to 1 of 2 groups. GROUP 1: Participants receive a packet of existing information materials about colorectal cancer prevention, screening, and genetic testing to review at their own pace over 6-10 weeks. Participants may optionally receive a CoGENES training session within 2 weeks post-intervention. GROUP 2: Participants receive a CoGENES training session over 45-60 minutes. After completion of study intervention, participants are followed up at 8 weeks, 6 months and 12 months.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
Yes
USC / Norris Comprehensive Cancer Center
Los Angeles, California, United States
Start Date
June 20, 2024
Primary Completion Date
June 20, 2026
Completion Date
June 20, 2027
Last Updated
January 12, 2026
140
ESTIMATED participants
Best Practice
OTHER
Health Promotion and Education
OTHER
Survey Administration
OTHER
Lead Sponsor
University of Southern California
Collaborators
NCT04704661
NCT06349642
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions